| Common name: | ATR1 |
| Defline: | (1 of 2) PTHR11139:SF69 - SERINE/THREONINE-PROTEIN KINASE ATR; ATM/ATR-related phosphatidylinositol 3-kinase |
| Description: | DNA damage sensing protein kinase homolog; related to ataxia telangiectasia RAD3/ATRprotein. PI3K related |
| Synonyms: | ATR1,g11448.t1 |
| Chromosome: | chromosome 10 |
We did not create a plasmid for this gene.
We did not determine any protein-protein interactions for this gene.
| Insertion Junction | Mutant Strain | Insertion Junction Feature | Confidence (%) | Genome Version |
|---|---|---|---|---|
| CLIP2.010630_1 | CLIP2.010630 | intron | 80 | 6.1 |
| CLIP2.010630_2 | CLIP2.010630 | intron | 80 | 6.1 |
| CLIP2.018156_1 | CLIP2.018156 | intron | 80 | 6.1 |
| CLIP2.018156_2 | CLIP2.018156 | intron | 80 | 6.1 |
| CLIP2.018844_1 | CLIP2.018844 | CDS | 80 | 6.1 |
| CLIP2.018844_2 | CLIP2.018844 | CDS | 80 | 6.1 |
| CLIP2.027107_1 | CLIP2.027107 | intron | 80 | 6.1 |
| CLIP2.027107_2 | CLIP2.027107 | intron | 80 | 6.1 |
| CLIP2.032775_1 | CLIP2.032775 | intron | 80 | 6.1 |
| CLIP2.032775_2 | CLIP2.032775 | intron | 80 | 6.1 |
| LMJ.RY0402.042384_1 | LMJ.RY0402.042384 | CDS | 73 | 5.5 |
| LMJ.RY0402.076508_1 | LMJ.RY0402.076508 | intron | 58 | 5.5 |
| LMJ.RY0402.103728_1 | LMJ.RY0402.103728 | intron | 73 | 5.5 |
| LMJ.RY0402.113831_1 | LMJ.RY0402.113831 | CDS | 58 | 5.5 |
| LMJ.RY0402.113831_2 | LMJ.RY0402.113831 | intron | 58 | 5.5 |
| LMJ.RY0402.131757_1 | LMJ.RY0402.131757 | intron | 73 | 5.5 |
| LMJ.RY0402.171224_1 | LMJ.RY0402.171224 | intron | 73 | 5.5 |
| LMJ.RY0402.172200_2 | LMJ.RY0402.172200 | CDS | 73 | 5.5 |
| PFAM: | PF02259 |
| PANTHER: | PTHR11139 PTHR11139:SF69 |
| KEGG_ec: | EC:2.7.11.1 |
| KEGG_orthology: | K06640 |
| KOG: | |
| Gene ontology terms:: | GO:0005488, GO:0005515 |
| Best arabidopsis TAIR name: | AT5G40820.1 |
| Best arabidopsis TAIR symbol: | ATATR,ATR,ATRAD3 |
| Best arabidopsis TAIR defline: | Ataxia telangiectasia-mutated and RAD3-related |
| Phytozome Locus Page |
Mutants in this gene exhibit a phenotype under the following conditions:
| Bleomycin sulfate, screen 2 of 2 ( 99% confidence (FDR = 0.00081)) |
| Cisplatin, screen 1 of 4 ( 99% confidence (FDR = 0.0027)) |
| Cisplatin, screen 2 of 4 ( 99% confidence (FDR = 7.1e-10)) |
| Cisplatin, screen 3 of 4 ( 99% confidence (FDR = 1.4e-06)) |
| Cisplatin, screen 4 of 4 ( 99% confidence (FDR = 3.8e-07)) |
| Hydroxyurea, screen 2 of 2 ( 99% confidence (FDR = 0.00093)) |
| Methyl methanesulfonate, screen 1 of 4 ( 98% confidence (FDR = 0.018)) |
| Methyl methanesulfonate, screen 2 of 4 ( 99% confidence (FDR = 2.9e-07)) |
| Methyl methanesulfonate, screen 3 of 4 ( 99% confidence (FDR = 4.4e-07)) |
| Methyl methanesulfonate, screen 4 of 4 ( 99% confidence (FDR = 6.4e-06)) |
| Mitomycin C, screen 1 of 4 ( 73% confidence (FDR = 0.27)) |
| Mitomycin C, screen 2 of 4 ( 99% confidence (FDR = 4.5e-06)) |
| Mitomycin C, screen 3 of 4 ( 99% confidence (FDR = 5.9e-06)) |
| Mitomycin C, screen 4 of 4 ( 99% confidence (FDR = 3.7e-06)) |
| Zeocin, screen 1 of 5 ( 99% confidence (FDR = 2.8e-05)) |
| Zeocin, screen 3 of 5 ( 99% confidence (FDR = 3.9e-06)) |
| Zeocin, screen 4 of 5 ( 99% confidence (FDR = 7.4e-05)) |
| Zeocin, screen 5 of 5 ( 99% confidence (FDR = 8.2e-06)) |
Note: FDR indicates the likelihood that a particular genotype-phenotype relationship is incorrect. Not all mutants in a particular gene show the same phenotype. Please see the mutant pages for each mutant's phenotypes. Complementation is needed to definitively prove a genotype-phenotype link. These data are from a pooled phenotyping experiment.
If you reference the phenotypic data above in a manuscript, please cite: Fauser et al. 2022 Nature Genetics.